Zobrazeno 1 - 10
of 95
pro vyhledávání: '"alflutop"'
Publikováno v:
Современная ревматология, Vol 18, Iss 4, Pp 80-88 (2024)
Objective: to investigate the efficacy of Alflutop therapy in patients with knee osteoarthritis (OA) with or without concomitant diseases. Material and methods. The large-scale, multicenter prospective, open-label, observational, non-interventional I
Externí odkaz:
https://doaj.org/article/bc461d6e3e2041459ea23c7469c33e36
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 1, Pp 104-108 (2024)
The aim of the study – to evaluate the effectiveness of the drug Alflutop (bioactive concentrate of small marine fish), as well as its effect on microcirculation parameters in patients with osteoarthritis (OA) of small joints of the hands.Patients
Externí odkaz:
https://doaj.org/article/1a8d71f6d37c4759bf385fb4750a69b1
Autor:
A. M. Lila, A. E. Karateev, L. I. Alexeeva, E. A. Taskina, An. B. Danilov, S. A. Zhivolupov, I. N. Samartsev, E. R. Barantsevich, A. P. Rachin
Publikováno v:
Современная ревматология, Vol 18, Iss 1, Pp 70-75 (2024)
The use of slow-acting disease-modifying symptomatic drugs, such as bioactive concentrate from small marine fish (BCSMF, Alflutop), is considered a potential element of complex therapy for chronic non-specific back pain (CNBP).Objective: to evaluate
Externí odkaz:
https://doaj.org/article/a3046a3c19e0442cb8acc20b77eb431f
Publikováno v:
Современная ревматология, Vol 17, Iss 4, Pp 75-85 (2023)
Osteoarthritis (OA) is one of the most important medical and social problems due to the steady increase in morbidity and disability. Prevention, management of risk factors, and early treatment of OA are critical.Objective of the ISKRA study was to ev
Externí odkaz:
https://doaj.org/article/2d4e5be1c18d4a168c745037692cb6e8
Publikováno v:
Современная ревматология, Vol 17, Iss 2, Pp 57-64 (2023)
Evaluation of the effect of new drugs should be carried out in randomized controlled trials (RCTs), and observational studies (OSs) are carried out to confirm and refine the results obtained in RCTs, for example, to study the effectiveness of drugs i
Externí odkaz:
https://doaj.org/article/d67a3e1fb02b402aadacfee948485e88
Publikováno v:
Klinicist, Vol 16, Iss 3, Pp 48-57 (2023)
Back pain (BP) is a major public health problem worldwide with high prevalence and disability. In most cases are associated with degenerative spinal disease (degenerative disc disease, DDD), myofascial syndrome, facet joint syndrome, spinal spondylos
Externí odkaz:
https://doaj.org/article/96bdd25b3fad48658ef00256d59bc234
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 3, Pp 306-313 (2022)
This review is focused on the issue of terminology in patients with multiple coexisting diseases in modern clinical practice. We articulate that multimorbidity is one of the leading problems in the field of public healthcare and that the treatment of
Externí odkaz:
https://doaj.org/article/2a7e4501ae4e43b7a573c9d31335fdce
Publikováno v:
Современная ревматология, Vol 16, Iss 3, Pp 60-66 (2022)
Objective: to evaluate efficacy and safety of the use of a bioactive concentrate of small marine fish (Alflutop) in patients with vertebrogenic sciatica (SC).Patients and methods. The study included 30 patients with persistent (more than 3 months) ve
Externí odkaz:
https://doaj.org/article/e5f0a688ed0e4b51b819cff2c614654d
Autor:
N. A. Shostak, A. A. Klimenko, N. A. Demidova, A. A. Kondrashov, D. Yu. Andryashkina, Yu. M. Saakyan, G. A. Varaksin, A. Yu. Tarantina
Publikováno v:
Klinicist, Vol 15, Iss 1-4, Pp 31-41 (2022)
The new coronavirus infection (COVID-19) is associated with a wide spectrum of various clinical manifestations including involvement of the musculoskeletal system which can persist for a long time after the infection. Supposedly, pathogenesis of musc
Externí odkaz:
https://doaj.org/article/102d87c20cd94009b2ba95ead34c3387
Publikováno v:
Современная ревматология, Vol 15, Iss 6, Pp 117-123 (2021)
The review presents an analysis of the therapeutic effect in osteoarthritis (OA) of the original complex injectable drug Alflutop (bioactive concentrate of small marine fish), which is one of the most widely used symptomatic slow acting drugs (SYSADO
Externí odkaz:
https://doaj.org/article/80f69fcda3774d4d89b49df2eb4897f7